Luke Harris

409 total citations
15 papers, 226 citations indexed

About

Luke Harris is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Luke Harris has authored 15 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Luke Harris's work include HER2/EGFR in Cancer Research (5 papers), Synthesis and pharmacology of benzodiazepine derivatives (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Luke Harris is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Synthesis and pharmacology of benzodiazepine derivatives (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Luke Harris collaborates with scholars based in United States. Luke Harris's co-authors include Albert E. Munson, Richard A. Carchman, Philip M. Carabateas, Sara Smith, Ravi Chari, Michael L. Miller, S. G. Bradley, Thomas A. Keating, Alan Wilhelm and Rajeeva Singh and has published in prestigious journals such as Analytical Chemistry, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Luke Harris

14 papers receiving 207 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luke Harris United States 10 88 68 68 59 36 15 226
Wilhelmus E. A. de Witte Netherlands 10 25 0.3× 211 3.1× 58 0.9× 53 0.9× 47 1.3× 17 349
Elliot D. Mock Netherlands 7 56 0.6× 139 2.0× 74 1.1× 13 0.2× 10 0.3× 11 293
Hsin Yeh Taiwan 10 89 1.0× 121 1.8× 74 1.1× 60 1.0× 17 0.5× 19 312
Anastasia Sideri Greece 8 59 0.7× 281 4.1× 36 0.5× 13 0.2× 20 0.6× 8 470
Harveen Kaur New Zealand 11 51 0.6× 224 3.3× 24 0.4× 13 0.2× 11 0.3× 19 326
Paweł Znojek Czechia 9 29 0.3× 143 2.1× 77 1.1× 11 0.2× 7 0.2× 11 331
G. Holme Canada 11 35 0.4× 94 1.4× 12 0.2× 24 0.4× 41 1.1× 20 354
Xiaowen Yang United Kingdom 6 80 0.9× 421 6.2× 26 0.4× 13 0.2× 29 0.8× 6 472
Martha Shackleton Ireland 9 41 0.5× 78 1.1× 20 0.3× 88 1.5× 6 0.2× 10 331

Countries citing papers authored by Luke Harris

Since Specialization
Citations

This map shows the geographic impact of Luke Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Harris more than expected).

Fields of papers citing papers by Luke Harris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Harris. The network helps show where Luke Harris may publish in the future.

Co-authorship network of co-authors of Luke Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Luke Harris. A scholar is included among the top collaborators of Luke Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke Harris. Luke Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gavrilescu, L. Cristina, Yulius Y. Setiady, Ling Dong, et al.. (2020). Abstract B21: Synergistic antitumor immunity observed with combination FRα-targeting antibody-drug conjugate plus anti-PD-1 therapy is CD8+ cell dependent. Cancer Immunology Research. 8(4_Supplement). B21–B21. 4 indexed citations
2.
Archer, Katie E., James R. Woods, Luke Harris, et al.. (2019). Synthesis of Highly Potent N-10 Amino-Linked DNA-Alkylating Indolinobenzodiazepine Antibody–Drug Conjugates (ADCs). ACS Medicinal Chemistry Letters. 10(8). 1211–1215. 9 indexed citations
3.
Archer, Katie E., Alan Wilhelm, Nicholas C. Yoder, et al.. (2019). Effect of Linker Stereochemistry on the Activity of Indolinobenzodiazepine Containing Antibody–Drug Conjugates (ADCs). ACS Medicinal Chemistry Letters. 10(8). 1193–1197. 11 indexed citations
4.
Archer, Katie E., Luke Harris, Erin K. Maloney, et al.. (2019). Optimizing Lysosomal Activation of Antibody–Drug Conjugates (ADCs) by Incorporation of Novel Cleavable Dipeptide Linkers. Molecular Pharmaceutics. 16(12). 4817–4825. 33 indexed citations
5.
6.
Shi, Chuan, Shalom D. Goldberg, Vadim Dudkin, et al.. (2018). LC/MS/MS Bioanalysis of Protein–Drug Conjugates—The Importance of Incorporating Succinimide Hydrolysis Products. Analytical Chemistry. 90(8). 5314–5321. 13 indexed citations
7.
Liu, Yimao, Katharine C. Lai, Luke Harris, et al.. (2018). Abstract 2900: Evaluation of endoglin/CD105 as a tumor vasculature target with antibody drug conjugates. Cancer Research. 78(13_Supplement). 2900–2900. 2 indexed citations
8.
9.
Vitharana, Dilrukshi, Alan Wilhelm, Luke Harris, et al.. (2016). Abstract 2965: In vitro and in vivo activity of a site-specific SeriMab antibody-drug conjugate (ADC) using an indolino-benzodiazepine DNA-alkylating agent. Cancer Research. 76(14_Supplement). 2965–2965. 1 indexed citations
10.
Aceto, Mario D., et al.. (1993). Dependence studies of new compounds in the rhesus monkey, rat and mouse (1992). PsycEXTRA Dataset. 41. 338–80.
11.
Bradley, S. G., et al.. (1979). Susceptibility of Naegleria fowleri to delta 9-tetrahydrocannabinol. Antimicrobial Agents and Chemotherapy. 16(5). 674–679. 14 indexed citations
12.
Smith, Sara, et al.. (1978). Structure-activity relationships of natural and synthetic cannabinoids in suppression of humoral and cell-mediated immunity.. Journal of Pharmacology and Experimental Therapeutics. 207(1). 165–170. 34 indexed citations
13.
Carchman, Richard A., Luke Harris, & Albert E. Munson. (1976). The inhibition of DNA synthesis by cannabinoids.. PubMed. 36(1). 95–100. 52 indexed citations
14.
Carabateas, Philip M. & Luke Harris. (1966). Analgesic Antagonists. I. 4-Substituted 1-Acyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepines. Journal of Medicinal Chemistry. 9(1). 6–10. 27 indexed citations
15.
Carabateas, Philip M., Alexander R. Surrey, & Luke Harris. (1964). Synthesis and Antitussive Activity of a New Heterocyclic Ring System. Some 1,2-Diazabicyclo[2.2.2]octanes. Journal of Medicinal Chemistry. 7(3). 293–297. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wilhelmus E. A. de Witte Breakdown of academic impact, for papers by Elliot D. Mock Breakdown of academic impact, for papers by Hsin Yeh Breakdown of academic impact, for papers by Anastasia Sideri Breakdown of academic impact, for papers by Harveen Kaur Breakdown of academic impact, for papers by Paweł Znojek Breakdown of academic impact, for papers by G. Holme Breakdown of academic impact, for papers by Xiaowen Yang Breakdown of academic impact, for papers by Martha Shackleton
Rankless by CCL
2026